Search

everythinglearnresearchcommunity

for

Search:↓

Herbs can potentially treat hair loss by inhibiting a key enzyme and promoting hair growth, and deficiencies in zinc, biotin, and iron are linked to hair loss.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Common acne treatments can cause various side effects, like skin irritation and more serious issues, but combination therapies are often more effective and better tolerated.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Minoxidil effectively treats female pattern hair loss.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Finasteride effectively treats male hair loss, improving growth and density.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.